Stock Events

Stock Events

Vioquest Pharmaceuticals 

$0
3
-$0-3.23% Monday 21:00

Statistics

Day High
0
Day Low
0
52W High
0
52W Low
0
Volume
100
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

20AugExpected
Q3 2006
Q4 2006
Q1 2007
Q2 2007
Q3 2007
Q1 2008
Q2 2008
-0.63
-0.54
-0.46
-0.38
Expected EPS
N/A
Actual EPS
-0.375

People Also Follow

This list is based on the watchlists of people on Stock Events who follow VOQP. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. is a global healthcare company that develops medications and vaccines across various therapeutic areas, directly competing with Vioquest's product lines.
Pfizer
PFE
Mkt Cap140.15B
Pfizer Inc. is involved in the discovery, development, and manufacture of healthcare products including medicines and vaccines, similar to Vioquest Pharmaceuticals.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson engages in the research and development, manufacture and sale of a broad range of products in the healthcare field, competing in similar markets as Vioquest.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline plc specializes in the creation and marketing of pharmaceutical and healthcare products, including those in the same categories as Vioquest.
Novartis
NVS
Mkt Cap237.61B
Novartis AG operates globally, providing solutions in pharmaceuticals that directly compete with Vioquest's therapeutic areas.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie Inc. is a research-based biopharmaceutical company that develops and markets advanced therapies, competing with Vioquest in specific drug categories.
AMGEN
AMGN
Mkt Cap160.66B
Amgen Inc. focuses on human therapeutics and operates in the same biotechnological sectors as Vioquest, making them direct competitors.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol-Myers Squibb Company, a global biopharmaceutical company, develops prescription drugs and biologics in several therapeutic areas, competing with Vioquest.
Lilly(Eli) &
LLY
Mkt Cap772.28B
Eli Lilly and Company is engaged in the discovery, development, manufacture, and sale of a range of pharmaceutical products, competing in the same space as Vioquest.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals, Inc. is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions, similar to Vioquest.

About

VioQuest Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of clinical stage drug therapies for the treatment of oncology and infectious diseases. Its lead product includes Xyfid, which is under development for the treatment and prevention of hand-foot syndrome. The company's products also consist of VQD-002, a nucleoside analog that is in Phase I clinical trials for the treatment of cancer; and Lenocta, a small molecule inhibitor of various protein tyrosine phosphatases, which is in Phase IIa clinical trials for the treatment of melanoma, renal cell carcinoma, and other solid tumors. VioQuest Pharmaceuticals also provides chiral products, technology, and custom synthesis development services to pharmaceutical and fine chemical companies in various stages of a products' lifecycle. The company was founded in 2000 and is headquartered in Basking Ridge, New Jersey.
Show more...
CEO
Mr. Mark D. Dacko
Employees
3
Country
US
ISIN
US9276252023

Listings

OTC Link
US
VOQP

0 Comments

Share your thoughts

FAQ

What is Vioquest Pharmaceuticals stock price today?▼
The current price of VOQP is $0 USD — it has decreased by -3.23% in the past 24 hours. Watch Vioquest Pharmaceuticals stock price performance more closely on the chart.
What is Vioquest Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Vioquest Pharmaceuticals stocks are traded under the ticker VOQP.
What were Vioquest Pharmaceuticals earnings last quarter?▼
VOQP earnings for the last quarter are -0.38 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does Vioquest Pharmaceuticals have?▼
As of April 04, 2026, the company has 3 employees.
In which sector is Vioquest Pharmaceuticals located?▼
Vioquest Pharmaceuticals operates in the Health Care sector.
When did Vioquest Pharmaceuticals complete a stock split?▼
The last stock split for Vioquest Pharmaceuticals was on April 30, 2008 with a ratio of 1:10.
Where is Vioquest Pharmaceuticals headquartered?▼
Vioquest Pharmaceuticals is headquartered in Basking Ridge, US.